Select Category
All

IP Group maintains position as the UK’s lead investor in spinouts

IP Group eyes future royalties from obesity drug candidates following Pfizer/Metsera deal

Half Year 2025 Interview with Greg Smith

Half Year Results Webinar 2025

Mike Molinari of IP Group Australia

Spotlighting: Hysata

Craig Richardson of IP Group plc talking about Genomics

Spotlighting: Genomics

Dr Lee Thornton discussing IP Group portfolio company Intrinsic

Spotlighting: Intrinsic

Capital Markets Day 2025

IP Group Capital Markets Day 2025 - CEO Greg Smith

Capital Markets Day 2025 Highlights